Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.
about
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma.A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge.
P2860
Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@en
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@nl
type
label
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@en
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@nl
prefLabel
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@en
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@nl
P2093
P2860
P1476
Comparison of pegylated interf ...... ith cutaneous T-cell lymphoma.
@en
P2093
A C Hüsken
A Tsianakas
M Schiller
S Beissert
P2860
P356
10.1111/J.1468-3083.2011.04011.X
P577
2011-03-09T00:00:00Z